EORP registry: what determines a good outcome from atrial fibrillation ablation in the 'real world'.

18 June 2017 (08:30 - 08:48)

Organised by:

About the speaker

Doctor Nikolaos Dagres

Charité - University Medicine Berlin, Berlin (Germany)

4 More presentations in this session

Presentation thumbnail

European Atrial Fibrillation Ablation Registry: do outcomes in the real-world compare with trials ?

Professor J. Kautzner (Prague, CZ)

Presentation thumbnail

Epicardial/hybrid atrial fibrillation ablation registry (EHAFAR): how does a hybrid approach compare to a transcatheter approach ?

Professor M. Blomstrom-Lundqvist (Orebro, SE)

Presentation thumbnail

Practice in perspective: can registry data guide future developments in atrial fibrillation ablation?

Doctor J. de Bono (Birmingham, GB)

Presentation thumbnail

Preventing progression of atrial fibrillation: a real-world analysis of a reactive atrial-antitachycardia pacing feature in CIEDs

Professor G. Boriani (Modena, IT)

Access the full session

Session thumbnail

Atrial fibrillation and ablation or devices: what do registries tell us?

The Event

EHRA EUROPACE - CARDIOSTIM 2017

18 June 2017 08:30 CET

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources